12
Participants
Start Date
October 31, 2007
Primary Completion Date
March 31, 2008
Study Completion Date
GSK561679 tablet or solution
GSK Investigational Site, Lexington
Lead Sponsor
GlaxoSmithKline
INDUSTRY